Careers

“At Sensei, there is a robust understanding of target selection, biochemical characterization, and how to integrate novel antibody-oriented technologies into therapeutic development. There currently is a diversity of targetable immune checkpoints which provide new avenues to the induction of anti-tumor immune responses. Hence, our innovative immunotherapeutic antibody programs have the potential to deliver active immunotherapy to larger populations of cancer patients.”

“I am fortunate to work with highly talented and committed individuals who push the boundaries of scientific curiosity while developing innovative therapeutics for cancer. Our ImmunoPhage™ bacteriophage platform embodies data-driven research as a robust design approach leveraging both the innate and adaptive immune response revolutionizing immunotherapy.”

“It is a great privilege to be part of and witness Sensei’s growth to an exceptional company with a mission to develop novel therapeutic solutions for cancer treatment. Our ImmunoPhage™ platform is a unique approach to develop new treatments that we hope will enhance and preserve the quality of life for those with a cancer diagnosis. At Sensei, being part of a diverse team that works collaboratively within a multi-faceted environment where every member of the team embraces formidable challenges to find evidence-based solutions, is an experience unparalleled to any other I have had.”